Study explores promise, limitations of 18F-FLT in cancer imaging

05/20/2013 | MolecularImaging.net

A review published in The Journal of Nuclear Medicine found that while 18F-FLT has been seen as a promising tracer for imaging cancer proliferation, its performance falls short of the standard FDG. In one study, 18F-FDG showed higher sensitivity in detecting pancreatic tumors. In another study, 18F-FLT was found to have lower uptake than FDG in head and neck cancers. "As F-18 FLT finds more applications in proliferation imaging, its benefits and limitations will be better known," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT